NRC
NASDAQ · Health Care
National Research Corp
$20.06
+0.49 (+2.50%)
Financial Highlights (FY 2026)
Revenue
136.46M
Net Income
11.52M
Gross Margin
61.9%
Profit Margin
8.4%
Rev Growth
-3.2%
D/E Ratio
5.65
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 61.9% | 61.9% | 67.8% | 67.8% |
| Operating Margin | 16.4% | 14.8% | 8.7% | 11.1% |
| Profit Margin | 8.4% | 8.0% | 8.0% | 10.0% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 136.46M | 141.01M | 186.15M | 191.25M |
| Gross Profit | 84.44M | 87.26M | 126.15M | 129.60M |
| Operating Income | 22.43M | 20.86M | 16.29M | 21.21M |
| Net Income | 11.52M | 10.71M | 14.97M | 19.17M |
| Gross Margin | 61.9% | 61.9% | 67.8% | 67.8% |
| Operating Margin | 16.4% | 14.8% | 8.7% | 11.1% |
| Profit Margin | 8.4% | 8.0% | 8.0% | 10.0% |
| Rev Growth | -3.2% | -3.2% | -4.1% | -8.3% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 184.93M | 184.93M | 19.99M | 16.96M |
| Total Equity | 32.73M | 32.73M | 255.25M | 239.89M |
| D/E Ratio | 5.65 | 5.65 | 0.08 | 0.07 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 30.01M | 29.46M | 21.30M | 22.66M |
| Free Cash Flow | — | — | 13.38M | 16.98M |